Excellent Response of Glioblastoma Multiforme to [ 177 Lu] Lu-PSMA Therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 40279656.
- Also identified by DOI 10.1097/RLU.0000000000005904.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The application of PSMA theranostic pairs in the glioblastoma multiform (GBM) has gained attention recently due to reports of PSMA radiotracer uptake in these tumors. The presented case is a 42-year-old man who had a known case of GBM with no response to standard-of-care therapy. However, 6 doses of 100-150 mCi 177 Lu-PSMA-617 therapy with short intervals of 4-5 weeks revealed excellent response on both MRI and 99m Tc-HYNIC-PSMA-11 scintigraphy. Though more dedicated studies are warranted, this case highlighted the potential efficacy of the 177 Lu-PSMA therapy in recurrent refractory GBM.
Medical subject headings
- Glioblastoma
- Lutetium
- Radioisotopes
- Dipeptides
- Heterocyclic Compounds, 1-Ring
- Brain Neoplasms